Description

OMEFOL 20MG (1X15)

Indications

OMEFOL 20MG is primarily indicated for the prevention and treatment of folate deficiency. It is particularly useful in populations at risk, including pregnant women, individuals with malabsorption syndromes, and those on certain medications that may interfere with folate metabolism. OMEFOL is also recommended in the management of hyperhomocysteinemia, which is associated with cardiovascular diseases and other health conditions.

Mechanism of Action

OMEFOL contains folic acid, which is a water-soluble B vitamin (B9). Folic acid plays a crucial role in DNA synthesis, repair, and methylation. It is essential for the production of red blood cells and is necessary for the proper functioning of the nervous system. By supplementing with OMEFOL, the body receives the necessary folate to support these vital processes, thereby preventing deficiencies that can lead to anemia and other health issues.

Pharmacological Properties

OMEFOL is rapidly absorbed in the gastrointestinal tract after oral administration. The peak plasma concentration of folic acid typically occurs within 1 to 2 hours. Folic acid is converted in the liver to its active form, tetrahydrofolate, which is then utilized in various biochemical pathways. The elimination half-life of folic acid is approximately 6 hours, with the majority excreted in the urine. OMEFOL is well-tolerated and has a low risk of toxicity, even at higher doses, due to its water-soluble nature.

Contraindications

OMEFOL should not be used in individuals with a known hypersensitivity to folic acid or any of the excipients in the formulation. It is also contraindicated in patients with untreated vitamin B12 deficiency, as folic acid can mask the symptoms of B12 deficiency and potentially lead to neurological complications. Caution is advised in patients with a history of hypersensitivity reactions to other medications.

Side Effects

OMEFOL is generally well-tolerated, and side effects are rare. However, some individuals may experience mild gastrointestinal disturbances, such as nausea, bloating, or diarrhea. Allergic reactions, although uncommon, can occur and may present as rash, itching, or swelling. In rare cases, high doses of folic acid may lead to neurological symptoms if vitamin B12 deficiency is present. It is important to monitor patients for any adverse reactions during treatment.

Dosage and Administration

The recommended dosage of OMEFOL 20MG varies depending on the indication and the patient’s specific needs. For the prevention of folate deficiency, the typical dosage is one tablet daily. In cases of established deficiency or increased need, such as during pregnancy, a healthcare provider may recommend higher doses. It is advisable to take OMEFOL with food to enhance absorption. Patients should follow their healthcare provider’s instructions regarding dosage and duration of therapy.

Interactions

OMEFOL may interact with certain medications, potentially affecting their efficacy or increasing the risk of side effects. Notably, anticonvulsants such as phenytoin and phenobarbital can reduce folate levels in the body, necessitating higher doses of folic acid. Additionally, methotrexate, a chemotherapy agent, can interfere with folate metabolism. It is essential for patients to inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements, to avoid potential interactions.

Precautions

Before starting OMEFOL, patients should discuss their medical history with their healthcare provider, particularly if they have a history of allergic reactions, liver disease, or any other significant medical conditions. Special caution should be exercised in patients with a history of vitamin B12 deficiency, as supplementation with folic acid can mask the symptoms of this deficiency. Regular monitoring of vitamin B12 levels may be warranted in such cases. Pregnant and breastfeeding women should also consult their healthcare provider before use, although OMEFOL is generally considered safe during pregnancy.

Clinical Studies

Clinical studies have demonstrated the efficacy of folic acid supplementation in reducing the risk of neural tube defects in developing fetuses when taken by pregnant women. A meta-analysis published in the American Journal of Clinical Nutrition highlighted that folic acid supplementation significantly decreases the incidence of these defects when initiated before conception and continued through the first trimester. Other studies have shown that adequate folate levels are associated with lower homocysteine levels, which may contribute to cardiovascular health. The findings support the use of OMEFOL in populations at risk for folate deficiency and its potential benefits in reducing related health risks.

Conclusion

OMEFOL 20MG is an effective supplement for preventing and treating folate deficiency. Its role in supporting DNA synthesis and red blood cell production makes it essential for various populations, particularly pregnant women and individuals with certain medical conditions. With its favorable safety profile and low risk of side effects, OMEFOL is a valuable addition to the management of folate-related health issues. Patients should always consult their healthcare provider to determine the appropriate dosage and ensure safe use.